Why your roadmap is killing your Series A

I've sat in a lot of Series A prep conversations. The ARR story is usually solid. The team slide is compelling. And then we get to the product slide — and there's a roadmap that looks like a Jira backlog with a Gantt chart wrapped around it.

That roadmap is going to cost you term sheets. Not because investors don't like features. But because a feature list tells them you don't have a product strategy — and a founder without a product strategy at Series A is a specific, well-understood risk that many funds won't take.

What investors are actually evaluating on the product slide

When a Series A investor looks at your product roadmap, they're not evaluating the quality of the features you've planned. They're evaluating whether you have a mental model for how your product creates and captures value — and whether that model can scale beyond what you've already built.

A feature list answers: What are you building? A product strategy answers: Why are you building these things in this order, and how does each one move the business toward a defensible market position?

The tell is simple: if you remove the company name from your roadmap, could it belong to any of your competitors? If yes, it's a feature list.

The three things a Series A roadmap needs to show

1. Revenue and retention logic, not feature categories

Every major initiative on your roadmap should be traceable to a specific outcome: an ARR milestone, a retention or NRR target, a new segment you're opening, or a competitive moat you're building.

A useful test: for each item on your roadmap, write one sentence explaining which customers this is for, what problem it solves, and what metric it will move. If you can't write that sentence in under thirty seconds, the item isn't defined enough to be on a Series A roadmap.

2. A sequencing rationale that makes strategic sense

Why these things in this order? The answer usually lives in one of three places: it's what your best ICP customers need to expand, it removes the most common objection in your sales process, or it closes a specific competitive gap.

3. Explicit trade-offs

A roadmap with no trade-offs is a wish list. The founders who instil the most confidence in Series A conversations are the ones who can articulate what they chose not to build — and why.

What to do in the next 30 days

1. Audit every item on your roadmap against a business outcome. If it doesn't have one, either assign one or remove it from the slide you show investors.
2. Write a one-paragraph product strategy. Not a mission statement — a crisp description of what you're building, for whom, and why doing those things in your planned sequence gets you to a defensible market position.
3. Identify the three things you explicitly chose not to build — and be ready to explain why. This is the part that builds the most investor confidence.